Cartilaginous exostosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Then we demonstrated that SPON1 was significantly up-regulated in 72 osteosarcoma specimens compared with benign osteochondroma samples and elevated SPON1 was positively correlated with MMP9 expression.
|
26032498 |
2015 |
Osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our study provides evidence of the contributions of SPON1 and the Fak and Src signaling to the progression of osteosarcoma and suggests that this axis may represent a potential therapeutic target for osteosarcoma.
|
26032498 |
2015 |
Secondary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Meanwhile, suppression of SPON1 in KHOS cells resulted in decreased pulmonary metastasis in vivo.
|
26032498 |
2015 |
Metastatic osteosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Knockdown of SPON1 expression in two metastatic osteosarcoma cell lines, HKOS and KRIB, dramatically suppressed cell migration and invasion.
|
26032498 |
2015 |
Osteosarcoma of bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our study provides evidence of the contributions of SPON1 and the Fak and Src signaling to the progression of osteosarcoma and suggests that this axis may represent a potential therapeutic target for osteosarcoma.
|
26032498 |
2015 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Treatment with recombinant SPON1 protein in two non-metastatic osteosarcoma cell lines, HOS and U2OS, significantly promoted cell migration and invasion in vitro.
|
26032498 |
2015 |
Childhood Osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our study provides evidence of the contributions of SPON1 and the Fak and Src signaling to the progression of osteosarcoma and suggests that this axis may represent a potential therapeutic target for osteosarcoma.
|
26032498 |
2015 |
Mental deterioration
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
These data suggest that SPON1 may be associated with the differential rate of cognitive decline in AD.
|
23535033 |
2014 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
These data suggest that SPON1 may be associated with the differential rate of cognitive decline in AD.
|
23535033 |
2014 |
Presenile dementia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The association of connectivity with the SPON1 variant at rs2618516 on chromosome 11 (11p15.2) reached connectome-wide, genome-wide significance after stringent statistical corrections were enforced, and it was replicated in an independent subsample. rs2618516 was shown to affect brain structure in an elderly population with varying degrees of dementia.
|
23471985 |
2013 |
Dementia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The association of connectivity with the SPON1 variant at rs2618516 on chromosome 11 (11p15.2) reached connectome-wide, genome-wide significance after stringent statistical corrections were enforced, and it was replicated in an independent subsample. rs2618516 was shown to affect brain structure in an elderly population with varying degrees of dementia.
|
23471985 |
2013 |
Degenerative polyarthritis
|
0.010 |
Biomarker
|
disease |
LHGDN |
F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activation.
|
18780763 |
2009 |
Carcinogenesis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
The data sets were divided into four compartments: (i) genes associated with carcinogenesis: in 14 studies, 1881 genes were extracted, 75 genes were identified in more than one study, and only 4 genes (PRKCBP1, SPON1, TACSTD1, and PTPRM) were identified in three studies.
|
18217975 |
2009 |